HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED
Clinical trials for HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED trials appear
Sign up with your email to follow new studies for HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Simple blood test may predict rare nerve disease before symptoms start
Knowledge-focused Recruiting nowThis study looks at a protein called NfL in the blood of people who carry a gene linked to a rare disease that damages nerves (hATTR amyloidosis). Researchers want to see if NfL levels can help detect when the disease starts, how it progresses, and how well treatments work. About…
Matched conditions: HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC
-
Scientists track rare nerve and heart disease in unexpected location
Knowledge-focused Recruiting nowThis study looks at 57 people aged 20 to 70 who carry a specific genetic change (Val50Met) linked to hereditary ATTR amyloidosis, a rare disease that can damage nerves and the heart. Researchers want to describe the different ways the disease shows up—mainly heart problems, mainl…
Matched conditions: HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED
Sponsor: Hospital 9 de Julio de Las Breñas • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC